Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will review the transparency of decision making by the Advisory Committee on Borderline Substances to ensure fairness and equity in their approvals process.

A review began in 2019 to improve the processes of the Advisory Committee on Borderline Substances. To date, three meetings have been held with industry representatives to take this forward and we are seeking further meetings with them to complete the work.